Danny Con

702 total citations
42 papers, 369 citations indexed

About

Danny Con is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Danny Con has authored 42 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 22 papers in Genetics and 12 papers in Surgery. Recurrent topics in Danny Con's work include Inflammatory Bowel Disease (22 papers), Microscopic Colitis (14 papers) and Liver Disease Diagnosis and Treatment (10 papers). Danny Con is often cited by papers focused on Inflammatory Bowel Disease (22 papers), Microscopic Colitis (14 papers) and Liver Disease Diagnosis and Treatment (10 papers). Danny Con collaborates with scholars based in Australia, Denmark and United States. Danny Con's co-authors include Peter De Cruz, Belinda Jackson, Daniel R. van Langenberg, Abhinav Vasudevan, Kathleen Gray, Danny Liew, Peter R. Gibson, Miles Sparrow, Daniel Clayton‐Chubb and Mayur Garg and has published in prestigious journals such as Gastroenterology, World Journal of Gastroenterology and Gastrointestinal Endoscopy.

In The Last Decade

Danny Con

37 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danny Con Australia 11 180 131 87 85 47 42 369
Katrine Carlsen Denmark 11 220 1.2× 154 1.2× 157 1.8× 78 0.9× 26 0.6× 28 493
Sabina Ali United States 9 95 0.5× 94 0.7× 70 0.8× 72 0.8× 25 0.5× 24 326
Eran Matz Israel 12 215 1.2× 186 1.4× 92 1.1× 32 0.4× 33 0.7× 52 384
Mark J. Integlia United States 6 167 0.9× 144 1.1× 189 2.2× 62 0.7× 26 0.6× 10 443
Gitit Tomer United States 11 246 1.4× 164 1.3× 127 1.5× 23 0.3× 95 2.0× 28 493
Luisa Avedano Italy 10 318 1.8× 226 1.7× 114 1.3× 53 0.6× 27 0.6× 20 603
Donna MacIsaac United States 7 121 0.7× 121 0.9× 145 1.7× 65 0.8× 65 1.4× 8 396
Mia Cilissen Netherlands 3 400 2.2× 275 2.1× 159 1.8× 101 1.2× 59 1.3× 7 531
Richard Moses United States 9 70 0.4× 69 0.5× 54 0.6× 40 0.5× 33 0.7× 39 203
Danny Wong United States 10 88 0.5× 177 1.4× 75 0.9× 18 0.2× 113 2.4× 20 465

Countries citing papers authored by Danny Con

Since Specialization
Citations

This map shows the geographic impact of Danny Con's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Con with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Con more than expected).

Fields of papers citing papers by Danny Con

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danny Con. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Con. The network helps show where Danny Con may publish in the future.

Co-authorship network of co-authors of Danny Con

This figure shows the co-authorship network connecting the top 25 collaborators of Danny Con. A scholar is included among the top collaborators of Danny Con based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danny Con. Danny Con is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choy, Matthew C., Kai Cheng, Danny Con, et al.. (2025). DOP057 Early serum and faecal cytokines predict clinical outcomes in Acute Severe Ulcerative Colitis: results from PREDICT-UC. Journal of Crohn s and Colitis. 19(Supplement_1). i196–i196.
2.
3.
Con, Danny, Crispin Corte, Ken Liu, et al.. (2025). Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation. Alimentary Pharmacology & Therapeutics. 62(10). 1003–1011. 1 indexed citations
4.
Con, Danny, et al.. (2024). Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B. Digestive Diseases and Sciences. 69(4). 1496–1506. 1 indexed citations
5.
Con, Danny, et al.. (2024). Use of artificial intelligence improves colonoscopy performance in adenoma detection: a systematic review and meta-analysis. Gastrointestinal Endoscopy. 101(1). 68–81.e8. 15 indexed citations
6.
Con, Danny & Peter De Cruz. (2024). Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling study. Intestinal Research. 22(4). 439–452. 1 indexed citations
7.
Grace, Josephine, Darren Wong, Danny Con, et al.. (2024). Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study. World Journal of Transplantation. 14(3). 94914–94914. 1 indexed citations
8.
Con, Danny, et al.. (2023). Upadacitinib in end stage renal disease: A case of acute severe ulcerative colitis. JGH Open. 7(12). 1012–1015. 3 indexed citations
9.
Con, Danny, et al.. (2023). The Effect of Aspirin Use on Incident Hepatocellular Carcinoma—An Updated Systematic Review and Meta-Analysis. Cancers. 15(13). 3518–3518. 9 indexed citations
10.
Vasudevan, Abhinav, Danny Con, Peter De Cruz, et al.. (2023). Clinical trial: Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study). Alimentary Pharmacology & Therapeutics. 59(4). 504–514. 6 indexed citations
11.
Smith, Rebecca L., et al.. (2021). Interrater reliability of the assessment of disease activity by gastrointestinal ultrasound in a prospective cohort of patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 33(10). 1280–1287. 6 indexed citations
12.
Con, Danny, et al.. (2021). Direct health care costs of managing perianal Crohn’s Disease in a population based cohort. Scandinavian Journal of Gastroenterology. 57(4). 432–438. 4 indexed citations
13.
14.
Con, Danny, et al.. (2021). Liver disease prevalence and severity in people with serious mental illness: a cross-sectional analysis using non-invasive diagnostic tools. Hepatology International. 15(3). 812–820. 5 indexed citations
15.
Con, Danny, Daniel R. van Langenberg, & Abhinav Vasudevan. (2021). Deep learning vs conventional learning algorithms for clinical prediction in Crohn's disease: A proof-of-concept study. World Journal of Gastroenterology. 27(38). 6476–6488. 22 indexed citations
16.
Ardalan, Zaid, Antony B. Friedman, Danny Con, et al.. (2021). Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation and its Location in Patients with an Ileoanal Pouch. Journal of Crohn s and Colitis. 16(1). 79–90. 19 indexed citations
17.
18.
Vasudevan, Abhinav, Danny Con, Raphael P. Luber, et al.. (2020). Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 52(7). 1174–1184. 19 indexed citations
19.
Smith, Rebecca L., et al.. (2020). P245 Inter-rater reliability of gastrointestinal ultrasound in the assessment of disease activity in patients with inflammatory bowel disease prior to commencing medical therapy. Journal of Crohn s and Colitis. 14(Supplement_1). S269–S271. 2 indexed citations
20.
Con, Danny & Peter De Cruz. (2016). Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and Tools. JMIR mhealth and uhealth. 4(1). e13–e13. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katrine Carlsen Breakdown of academic impact, for papers by Sabina Ali Breakdown of academic impact, for papers by Eran Matz Breakdown of academic impact, for papers by Mark J. Integlia Breakdown of academic impact, for papers by Gitit Tomer Breakdown of academic impact, for papers by Luisa Avedano Breakdown of academic impact, for papers by Donna MacIsaac Breakdown of academic impact, for papers by Mia Cilissen Breakdown of academic impact, for papers by Richard Moses Breakdown of academic impact, for papers by Danny Wong
Rankless by CCL
2026